Skip to main content
Figure 2 | Malaria Journal

Figure 2

From: The global pipeline of new medicines for the control and elimination of malaria

Figure 2

Sales (USD) of fixed dose artemisinin combination therapy 2006 2010. These data are compiled from estimates supplied by the WHO-prequalified manufacturers and from data provided by AMFm and include only WHO-prequalified or Global Fund-approved generic versions of the medicines. Sales of DHA/piperaquine have been around two million per year, and naphthoquine artemisinin around one million per year. Mefloquine-artesunate numbers are significantly lower. These numbers compare well with the lower range of the estimates predicted by the Clinton Foundation[42]. The total number of malaria patients was estimated by WHO to have fallen to 225 million in 2009[7].

Back to article page